CNSL
NEUTRALCambridge Nutritional Sciences Grants Options to CFO
The medical diagnostics company has granted share options to its CFO as part of the executive compensation program.
Cambridge Nutritional Sciences
3.2500GBX
0.00%
Market Cap
7.85M
Volume
357.34k
117% of avg
P/E Ratio
NaN
EPS (TTM)
Beta
1.47
Day Range
3.0550p - 3.4750p
52 Week Range
2.4150p3.2500p4.3800p
3.2500p
Upcoming Events
Mid 2026
Anticipated full impact of expanded sales team on revenue growth
High Impact Event
CNSL
GOODCambridge Nutritional Sciences plc Reports Profit Turnaround Despite Revenue Dip in Annual Results
The food sensitivity testing specialist has reported a significant profit turnaround despite a revenue dip, with improved margins and a positive outlook for future growth in the gut health market.
CNSL
NEUTRALCambridge Nutritional Sciences Announces Final Results Presentation
The healthcare company will host an investor presentation to discuss its full-year results.
CNSL
NEUTRALCambridge Nutritional Sciences Appoints New CFO
The healthcare diagnostics company has appointed a new Chief Financial Officer with extensive finance experience.
CNSL
NEUTRALCambridge Nutritional Sciences Announces Holding Change
The healthcare company has announced a change in shareholding, with IG Markets Limited increasing its stake to just under 3% of the voting rights.
CNSL
GOODCambridge Nutritional Sciences Reports Solid Profit Growth in 2025 Trading Update
The medical diagnostics company reports strong profit growth and an attractive valuation, despite some short-term challenges.
CNSL
NEUTRALCambridge Nutritional Sciences Resolves HSE Matter
The healthcare company has resolved a historical health and safety issue at one of its subsidiaries, with a minor fine imposed.
CNSL
NEUTRALCambridge Nutritional Sciences Grants Options to CEO
The medical diagnostics company has granted share options to its Chief Executive Officer.
CNSL
NEUTRALCambridge Nutritional Sciences Appoints New CEO
The healthcare company has appointed a new Chief Executive Officer to lead the business forward.
CNSL
NEUTRALCambridge Nutritional Sciences Announces Director Dealings
The healthcare company has announced changes to its major shareholdings.